Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Total Current Liabilities: 2013-2025

Historic Total Current Liabilities for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $49.3 million.

  • Ocular Therapeutix's Total Current Liabilities rose 35.58% to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.3 million, marking a year-over-year increase of 35.58%. This contributed to the annual value of $41.4 million for FY2024, which is 18.51% up from last year.
  • Per Ocular Therapeutix's latest filing, its Total Current Liabilities stood at $49.3 million for Q3 2025, which was up 14.82% from $42.9 million recorded in Q2 2025.
  • Ocular Therapeutix's 5-year Total Current Liabilities high stood at $49.3 million for Q3 2025, and its period low was $21.6 million during Q2 2021.
  • Over the past 3 years, Ocular Therapeutix's median Total Current Liabilities value was $35.1 million (recorded in 2023), while the average stood at $35.8 million.
  • In the last 5 years, Ocular Therapeutix's Total Current Liabilities spiked by 146.91% in 2021 and then declined by 18.23% in 2024.
  • Over the past 5 years, Ocular Therapeutix's Total Current Liabilities (Quarterly) stood at $26.3 million in 2021, then increased by 19.20% to $31.4 million in 2022, then increased by 11.15% to $34.9 million in 2023, then climbed by 18.51% to $41.4 million in 2024, then spiked by 35.58% to $49.3 million in 2025.
  • Its Total Current Liabilities stands at $49.3 million for Q3 2025, versus $42.9 million for Q2 2025 and $37.9 million for Q1 2025.